Home › Heart Failure › Washington
Heart Failure clinical trials in Washington
26 studies for Heart Failure are looking for participants at sites in Washington.
Cities in Washington
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Redmond
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07761117Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Providence Advanced Heart Disease and Transplant, Spokane
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 24, 2026 · NCT06736574A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Virginia Mason Medical Center, Seattle
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06424288Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Pulse Heart Institute, Puyallup
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Spokane, WA Investigative Site 10123, Spokane
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 132, Seattle
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
RecruitingPhase 2/3
29 Days – 17 Years · All sexes · Updated Aug 28, 2026 · NCT05714085AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
- Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Aug 27, 2026 · NCT06793371Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Olympia
RecruitingObservational study
All ages · All sexes · Updated Aug 20, 2026 · NCT00271180LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Seattle
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Aug 19, 2026 · NCT07288398A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Virginia Mason Medical Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Swedish Medical Center_Seattle, Seattle
- CHI Franciscan Research Center, Tacoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Seattle Children's Hospital, Seattle
RecruitingPhase 2
Ages 0 to 16 · All sexes · Updated Aug 10, 2026 · NCT06080074Assessment of CCM in HF With Higher Ejection Fraction
- Swedish Medical Center, Seattle
- Peace Health, Vancouver
Recruiting
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT05064709ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Recruiting
Ages 40 and older · All sexes · Updated Aug 3, 2026 · NCT06678841PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Repurposing Valsartan May Protect Against Pulmonary Hypertension
- University of Washington Medical Center, Seattle
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated May 4, 2026 · NCT06053580CCM OPEN HF Registry
- PeaceHealth Southwest Medical Center, Vancouver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07112924Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 24, 2026 · NCT06217302XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- University of Washington Medical Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06895070Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
- University of Washington, Seattle
Recruiting
Ages 40 and older · All sexes · Updated Mar 16, 2026 · NCT07105007Left vs Left Randomized Clinical Trial
- University of Washington, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05650658Cardiogenic Shock Working Group Registry
- University of Washington Medical Center, Seattle
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 6, 2025 · NCT04682483Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
- University of Washington Medicine, Seattle
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Mar 26, 2024 · NCT04703842Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
- University of Washington Medical Center, Seattle
Recruiting
Ages 18 and older · All sexes · Updated Feb 23, 2021 · NCT02537769From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.